YONGHE MEDICAL GROUP CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.15 HKD | -3.36% |
|
+7.48% | -54.55% |
| Mar. 28 | Yonghe Medical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 11 | Yonghe Medical to Widen Loss in 2023 | MT |
| Sales 2023 | 1.78B 245M 1.92B | Sales 2024 * | 2.13B 295M 2.31B | Capitalization | 560M 77.35M 605M |
|---|---|---|---|---|---|
| Net income 2023 | -546M -75.42M -590M | Net income 2024 * | -162M -22.38M -175M | EV / Sales 2023 | 0.68 x |
| Net Debt 2023 * | 783M 108M 846M | Net Debt 2024 * | 915M 126M 988M | EV / Sales 2024 * | 0.69 x |
| P/E ratio 2023 |
-2.16
x | P/E ratio 2024 * |
-3.42
x | Employees | 4,319 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 25.96% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.36% | ||
| 1 week | +7.48% | ||
| 3 months | -41.33% | ||
| 6 months | -65.15% | ||
| Current year | -54.55% |
1 week
1.07
1.21
1 month
0.911.26
Current year
0.912.65
1 year
0.918.52
3 years
0.9119.00
5 years
0.9119.00
10 years
0.9119.00
| Managers | Title | Age | Since |
|---|---|---|---|
Yu Zhang
CEO | Chief Executive Officer | 38 | 10-06-30 |
Zhimei Han
DFI | Director of Finance/CFO | 47 | 17-03-19 |
Yang Xu
COO | Chief Operating Officer | 45 | 19-09-01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Peng Kuan Chan
BRD | Director/Board Member | 61 | 21-05-31 |
Ji Hong Liang
BRD | Director/Board Member | 51 | 22-06-27 |
Yu Zhang
CEO | Chief Executive Officer | 38 | 10-06-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 1.15 | -3.36% | 173 000 |
| 24-04-29 | 1.19 | +2.59% | 273,000 |
| 24-04-26 | 1.16 | +3.57% | 222,500 |
| 24-04-25 | 1.12 | -0.88% | 83,500 |
| 24-04-24 | 1.13 | +2.73% | 171,000 |
Delayed Quote Hong Kong S.E., April 30, 2024 at 04:08 am EDT
More quotes
Yonghe Medical Group Co Ltd is a China-based company mainly engaged in hair transplant business. The Company's main business is to provide one-stop hair medical services through medical institutions, including hair transplantation, medical care, routine care and other ancillary services. The Company also provides hair repair products and scalp cleaning services.
Calendar
2024-08-25
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
1.15
HKD
Average target price
2.4
HKD
Spread / Average Target
+108.70%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -54.55% | 80M | |
| -7.44% | 1.45B |
- Stock Market
- Equities
- 2279 Stock
